Age and Blood Pressure Drive Arterial Stiffness Progression in Japanese Adults: New Risk Score Developed
Age, blood pressure, and metabolic risk factors can predict arterial stiffness progression over five years, a recent study has reported.
Published in Hypertension Research, a peer-reviewed journal under the Nature portfolio, this large-scale longitudinal analysis was conducted in Japan and involved 10,284 participants aged 30–69 years. The study aimed to identify predictors of increased brachial-ankle pulse wave velocity (baPWV ≥1400 cm/s), a validated surrogate for arterial stiffness.
Study Design and Cohort Details
This retrospective cohort study utilized data from health examinations conducted at Kagoshima Kouseiren Hospital between 2005 and 2019. From the original cohort, 6104 individuals (3394 men, 2710 women) with baseline baPWV <1400 cm/s and no history of cardiovascular medication were followed over five years. The primary outcome was progression to baPWV ≥1400 cm/s—a threshold indicating elevated arterial stiffness.
Key Findings
- Incidence: 32.6% of men and 24.8% of women developed baPWV ≥1400 cm/s over five years.
- Men: Significant predictors included age, systolic and diastolic blood pressure (SBP, DBP), heart rate (HR), fasting blood sugar (FBS), triglycerides (TG), and habitual drinking.
- Women: Significant predictors were age, SBP, DBP, HR, and smoking history.
- A risk score based on these factors achieved moderate predictive accuracy (Area Under the Curve [AUC]: 0.68 in men, 0.71 in women).
- A logistic regression-based equation provided higher predictive discrimination (AUC: 0.71 in men, 0.77 in women), outperforming the simpler score-based model.
By combining accessible clinical parameters into a validated predictive model, this study bridges a critical gap in the early identification of subclinical atherosclerosis risk.
Reference: Inadome N, Kawasoe S, Miyata M, et al. Risk prediction score and equation for progression of arterial stiffness using Japanese longitudinal health examination data. Hypertens Res. 2025;48:1690–1701. doi:10.1038/s41440-024-02057-z
